DMARDs (biologic)

Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study
Dimitrios A Pappas, Gregory St John, Carol J Etzel, Stefano Fiore, Taylor Blachley, Toshio Kimura, Rajeshwari Punekar, Kelechi Emeanuru, Jeannie Choi, Susan Boklage, Joel M Kremer

Annals of the Rheumatic Diseases Jan 2021, 80 (1) 96-102; DOI: 10.1136/annrheumdis-2020-217209
Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020
Olivier Lortholary, Mario Fernandez-Ruiz, John W Baddley, Oriol Manuel, Xavier Mariette, Kevin L Winthrop

Annals of the Rheumatic Diseases Dec 2020, 79 (12) 1532-1543; DOI: 10.1136/annrheumdis-2020-217092
Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritis
Chanakya Sharma, Samuel Whittle, Pari Delir Haghighi, Frada Burstein, Roee Sa'adon, Helen Isobel Keen

Annals of the Rheumatic Diseases Nov 2020, 79 (11) 1432-1437; DOI: 10.1136/annrheumdis-2020-217333
‘Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients’
Maya H Buch, Andrew Melville, Dennis G McGonagle

Annals of the Rheumatic Diseases Nov 2020, 79 (11) e140; DOI: 10.1136/annrheumdis-2019-215881
Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter
Nabiha Sbeih, Alexis Mathian, Marc Pineton de Chambrun, Raphael Lhote, Noël Zahr, Micheline Pha, Fleur Cohen-Aubart, Julien Haroche, Miguel Hié, Sophie Jouffroy, Neila Benameur, Hervé Devilliers, Zahir Amoura

Annals of the Rheumatic Diseases Nov 2020, 79 (11) e148; DOI: 10.1136/annrheumdis-2019-215732
Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial
Hermine I Brunner, Carlos Abud-Mendoza, Diego O Viola, Inmaculada Calvo Penades, Deborah Levy, Jordi Anton, Julia E Calderon, Vyacheslav G Chasnyk, Manuel A Ferrandiz, Vladimir Keltsev, Maria E Paz Gastanaga, Michael Shishov, Alina Lucica Boteanu, Michael Henrickson, Damon Bass, Kenneth Clark, Anne Hammer, Beulah N Ji, Antonio Nino, David A Roth, Herbert Struemper, Mei-Lun Wang, Alberto Martini, Daniel Lovell, Nicolino Ruperto

Annals of the Rheumatic Diseases Oct 2020, 79 (10) 1340-1348; DOI: 10.1136/annrheumdis-2020-217101
Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort
Raphael Micheroli, Christoph Tellenbach, Almut Scherer, Kristina Bürki, Karin Niederman, Michael J Nissen, Pascal Zufferey, Pascale Exer, Burkhard Möller, Diego Kyburz, Adrian Ciurea

Annals of the Rheumatic Diseases Sep 2020, 79 (9) 1203-1209; DOI: 10.1136/annrheumdis-2019-215934
Response to: ‘Response to: “Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients” by Fornaro et al’ by Agca et al
Marco Fornaro, Fabio Cacciapaglia, Vincenzo Venerito, Giuseppe Lopalco, Florenzo Iannone

Annals of the Rheumatic Diseases Sep 2020, 79 (9) e106; DOI: 10.1136/annrheumdis-2019-216407
Adalimumab dose tapering in patients with rheumatoid arthritis who are in long-standing clinical remission: results of the phase IV PREDICTRA study
Paul Emery, Gerd R Burmester, Esperanza Naredo, Luigi Sinigaglia, Ivan Lagunes, Franziska Koenigsbauer, Philip G Conaghan

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1023-1030; DOI: 10.1136/annrheumdis-2020-217246
Long-term effectiveness and safety of secukinumab for treatment of refractory mucosal and articular Behçet’s phenotype: a multicentre study
Filippo Fagni, Alessandra Bettiol, Rosaria Talarico, Giuseppe Lopalco, Elena Silvestri, Maria Letizia Urban, Paul A J Russo, Gerardo Di Scala, Giacomo Emmi, Domenico Prisco

Annals of the Rheumatic Diseases Aug 2020, 79 (8) 1098-1104; DOI: 10.1136/annrheumdis-2020-217108

Main menu

DMARDs (biologic)

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

DMARDs (biologic)

Pages